BNGO offering history
Every offering-related filing in Bionano Genomics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 620 filings back to Aug 31, 2007.
| Date | Filing | What it means | |
|---|---|---|---|
| May 8, 2026 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Oct 17, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Sep 16, 2025 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Sep 16, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Sep 11, 2025 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Apr 2, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Feb 21, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jan 14, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jan 10, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jan 8, 2025 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Jan 6, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jan 3, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jan 3, 2025 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Oct 31, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 12, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Aug 12, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jul 31, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jul 8, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jul 8, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 20, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jun 20, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 10, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| May 28, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Apr 8, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 8, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Nov 6, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Oct 26, 2023 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Oct 11, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Oct 11, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 10, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 8, 2023 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Apr 14, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Mar 10, 2023 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Oct 12, 2021 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Mar 24, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jan 21, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jan 19, 2021 | S-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| Jan 19, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jan 11, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jan 8, 2021 | S-3MEF → | REGISTERED | S-3MEF registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
BNGO offering FAQ
When did BNGO last execute an offering?
Per SEC filings, Bionano Genomics, Inc.'s most recent priced offering document is a 424B5 filed 2025-10-17. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did BNGO last announce or register an offering?
The most recent registration is a S-3 filed 2026-05-08. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.